Published in Korean J Radiol on April 03, 2017
Antithyroid drugs. N Engl J Med (2005) 7.43
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid (2011) 7.17
Clinical practice. Graves' disease. N Engl J Med (2008) 5.78
The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med (2012) 1.84
High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab (2002) 1.78
An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med (2013) 1.59
Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) (1995) 1.44
Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab (1996) 1.40
A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol (2005) 1.26
Absolute quantification in SPECT. Eur J Nucl Med Mol Imaging (2011) 1.23
Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab (2008) 1.23
Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab (2000) 1.22
Assessment of thyroid function and anatomy with technetium-99m as pertechnetate. J Nucl Med (1968) 1.09
High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [131I]iodide therapy in Graves' disease. Nucl Med Commun (2005) 1.08
Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study. Pediatrics (2008) 1.06
Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid (1997) 1.03
Management of Graves Disease: A Review. JAMA (2015) 1.01
Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT. EJNMMI Res (2013) 0.95
Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study. J Endocrinol Invest (2008) 0.92
The predictive role of 24h RAIU with respect to the outcome of low fixed dose radioiodine therapy in patients with diffuse toxic goiter. Hormones (Athens) (2013) 0.90
Loss of pertechnetate from the human thyroid. J Nucl Med (1969) 0.87
The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging (2002) 0.87
Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. Eur J Endocrinol (2001) 0.86
Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Eur J Clin Invest (2004) 0.86
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease? Clin Endocrinol (Oxf) (1984) 0.85
Use of thyroid ultrasound volume in calculating radioactive iodine dose in hyperthyroidism. Thyroid (2000) 0.83
Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clin Endocrinol (Oxf) (1987) 0.83
Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus. Oncol Rep (2003) 0.82
Maximum Standardized Uptake Value of (99m)Tc Hydroxymethylene Diphosphonate SPECT/CT for the Evaluation of Temporomandibular Joint Disorder. Radiology (2016) 0.80
The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma. Nucl Med Mol Imaging (2014) 0.80
Data blending with 99mTc in evaluating thyroid anatomy by scintillation scanning. J Nucl Med (1968) 0.79
Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake. Clin Physiol Funct Imaging (2006) 0.79
Correlation between Semi-Quantitative (18)F-FDG PET/CT Parameters and Ki-67 Expression in Small Cell Lung Cancer. Nucl Med Mol Imaging (2016) 0.77
Quantitative single-photon emission computed tomography/computed tomography for technetium pertechnetate thyroid uptake measurement. Medicine (Baltimore) (2016) 0.77
Response rate and factors affecting the outcome of a fixed dose of RAI-131 therapy in Graves' disease: a 10-year Egyptian experience. Nucl Med Commun (2014) 0.76